Hims & Hers stock rises after announcing direct GLP-1 obesity drug partnership with Eli Lilly

Corroborated by 2 sources from 2 publishers

globalhealth4h ago

TL;DR

Hims & Hers reported a direct partnership with Eli Lilly to develop GLP-1 obesity medications, prompting its shares to climb.

Sources